The 5th 5-year Business Plan (FY2021 - FY2025)

Target and the latest Estimate for FY2025 KPI

		Target as of April 2021		Estimate as of April 2024
Revenue		1,600 Bn JPY		2.1 Tr JPY
Revenue in Oncology		> 600 Bn JPY		> 1.0 Tr JPY
Core Operating Profit ratio before R&D expense		40％		40％
ROE		> 16％		> 16％
DOE		> 8％		> 8.5％
Currency rate assumptions		１USD＝105JPY, １EUR＝120JPY		１USD=145JPY, １EUR＝155JPY

 

• The 5th 5-year Business Plan Update (Excerpt from Top Management Presentation, Financial Results of FY2023 Q4 on April 25th, 2024)
• <Original Presentation Material as of April 21st, 2021>
• <Streaming as of April 21st, 2021>

The 4th 5-year Business Plan Overview and Progress

(The following is an excerpt from the Value Report 2019.)

• <PDF> (0.51MB)
• <Ebook>

Revised Target for the 4th 5-Year Business Plan (October 31, 2018)

• <PDF> (0.75MB)